Chart of the Week: Panel Opportunities in Lung Cancer

This weeks CotW is from our recent webinar.  This figure demonstrates the results of an analysis focused on identifying biomarkers that are measured together frequently in clinical trials.  The goal of the analysis was to identify groups of biomarkers that are linked...

Chart of the Week: Protein IVDs Flatline Nucleic Acid IVDs Explode

This week we took a look at FDA-cleared and approved IVDs for oncology, and grouped them based on whether they measure proteins or nucleic acids.  Protein-based tests have historically been the dominant type used in the clinic, but this is changing rapidly.  Based on...